Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Genprex Gets FDA Fast Track Designation For REQORSA Immunogene Therapy In Combination With Keytruda For NSCLC Treatment


RTTNews | Jan 3, 2022 08:11AM EST

08:10 Monday, January 3, 2022 (RTTNews) - Genprex Gets FDA Fast Track Designation For REQORSA Immunogene Therapy In Combination With Keytruda For NSCLC Treatment

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC